Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F19VZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $139,735
Award facts
- Contract value 100% obligated
- $139,734.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $139,734.53 delivery order (Contract 4570347231) to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is set for completion by December 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and runs through December 2026.
The Enbrel auto-injector procurement supports military healthcare operations through DLA's Medical Supply Chain, which manages pharmaceutical distribution for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Enbrel is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, and this order fulfills anticipated medical supply requirements within the DLA's broader pharmaceutical vendor program. AmerisourceBergen's SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply specialty medications, biologics, vaccines, and associated medical devices across multiple therapeutic domains to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F19VZ?
SPE2DR26F19VZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F19VZ worth?
The government has obligated $139,735 on SPE2DR26F19VZ.
Is contract SPE2DR26F19VZ an order under another contract?
Yes. SPE2DR26F19VZ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19VZ competed?
The extent of competition for SPE2DR26F19VZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award